- Featured Product
- KD/KO Validated
TDP-43 (N-terminal) Rekombinanter Antikörper
TDP-43 (N-terminal) Rekombinant Antikörper für WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA
Konjugation
Unkonjugiert
CloneNo.
16A22
Kat-Nr. : 80002-1-RR
Synonyme
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | HeLa-Zellen, C6-Zellen, K-562-Zellen, Neuro-2a-Zellen |
Erfolgreiche IP | HAP1 cells, HeLa-Zellen |
Erfolgreiche Detektion in IHC-Autostainer | humanes Hirngewebe |
Erfolgreiche Detektion in IHC | Maushirngewebe, humanes Hirngewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
Erfolgreiche Detektion in IF-P | Rattenhirngewebe |
Erfolgreiche Detektion in IF/ICC | HeLa-Zellen, HepG2-Zellen, SH-SY5Y-Zellen |
Erfolgreiche Detektion in FC (Intra) | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunhistochemie (IHC)-AUTOSTAINER | IHC-AUTOSTAINER : 1:50-1:500 |
Immunhistochemie (IHC) | IHC : 1:1600-1:6400 |
Immunfluoreszenz (IF)-P | IF-P : 1:800-1:3200 |
Immunfluoreszenz (IF)/ICC | IF/ICC : 1:200-1:800 |
Durchflusszytometrie (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
WB | See 3 publications below |
IHC | See 1 publications below |
IF | See 3 publications below |
IP | See 1 publications below |
Produktinformation
80002-1-RR bindet in WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA TDP-43 (N-terminal) und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Maus |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | TDP-43 (N-terminal) fusion protein Ag1231 |
Vollständiger Name | TAR DNA binding protein |
Berechnetes Molekulargewicht | 43 kDa |
Beobachtetes Molekulargewicht | 43 kDa |
GenBank-Zugangsnummer | BC001487 |
Gene symbol | TDP-43 |
Gene ID (NCBI) | 23435 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The TARDBP gene encodes the TDP-43 protein, initially found to repress HIV-1 transcription by binding TAR DNA. TDP-43 has since been shown to bind RNA as well as DNA, and have multiple functions in transcriptional repression, translational regulation and pre-mRNA splicing. For instance, it is reported to regulate alternate splicing of the CTFR gene.
In 2006 Neumann et al. found that hyperphosphorylated, ubiquitinated and/or cleaved forms of TDP-43, collectively known as pathological TDP-43, play a major role in the disease mechanisms of ubiquitin-positive, tau- and alpha-synuclein-negative frontotemporal dementia (FTLD-U) and in amyotrophic lateral sclerosis (ALS).
Proteintech's 80002-1-RR is a rabbit recombinant TDP-43 antibody recognizing N-terminal TDP-43. It recognizes the intact 43 kDa protein as well as all posttranslationally modified and truncated forms in multiple applications. Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659, 19823856, 21666678, 22193176)
Recently TDP-43 has been reported to be overexpressed in triple negative breast cancer (TNBC) and it may be a potential target for TNBC diagnosis and drug design. (PMID: 29581274)
80002-1-RR antibody works well in IF experiment.
Protokolle
PRODUKTSPEZIFISCHE PROTOKOLLE | |
---|---|
WB protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Protokoll herunterladen |
IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Protokoll herunterladenl |
IF protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Protokoll herunterladen |
IP protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Protokoll herunterladen |
STANDARD-PROTOKOLLE | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
bioRxiv Patient-derived Induced Pluripotent Stem Cells as a Model to Study Frontotemporal Dementia Pathologies | ||
Nat Chem Biol Small-molecule dissolution of stress granules by redox modulation benefits ALS models | ||
Neural Regen Res 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis | ||
F1000Res The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence | ||